-

KARL STORZ Unifies Canada, US, and Veterinary Organizations to Form North America Region Led by Sonal Matai

New organizational structure will drive commercial growth, innovation, and overall business performance.

EL SEGUNDO, Calif.--(BUSINESS WIRE)--KARL STORZ, a family-owned medical technology company headquartered in Tuttlingen, Germany, today announced the creation of a North America region that unifies its US, Canada, and Veterinary businesses under the leadership of Sonal Matai.

KARL STORZ North America now encompasses six locations in the US and a Canadian and Veterinary hub in Mississauga, Ontario.

Share

Matai joined KARL STORZ in 2022 and was appointed to lead KARL STORZ United States in early 2024. As President of North America, Matai will now oversee key functions such as commercial operations, research and development, and manufacturing under a unified leadership structure for the region.

The formation of KARL STORZ North America reflects the company’s commitment to enhancing operational efficiency, service, and value to its customers across a broader geographic footprint.

“After 80 years, KARL STORZ’s mission remains the same – to improve patient lives,” said Matai, President of KARL STORZ North America. “The decision to unify our businesses across North America underscores our commitment to our customers and their evolving needs in patient care. This is an exciting opportunity to leverage exceptional talent from both countries, which will only strengthen our ability to bring solutions to market with greater speed and agility.”

Effective today, KARL STORZ North America encompasses six locations in the US and a Canadian and Veterinary hub in Mississauga, Ontario, a region recognized for its booming medical technology sector. Changes to the organizational structure will cause no anticipated disruption to services, product availability, or customer support.

About KARL STORZ

KARL STORZ is an innovative leader in endoscopic technology and surgical imaging solutions across virtually all surgical specialties. Its integrated OR solutions, including advancements in digital surgery, enhance collaboration to improve clinical efficiency and outcomes inside the hospital and across other sites of care. With subsidiaries around the world, KARL STORZ is a family-owned company based in Germany that designs, engineers, manufactures, and markets all its products with an emphasis on visionary design, precision craftsmanship, and clinical effectiveness. For more information, visit www.karlstorz.com.

Contacts

Susan Mancia
Mobile: 562-841-1515
E-mail: susan.mancia@karlstorz.com

KARL STORZ


Release Versions

Contacts

Susan Mancia
Mobile: 562-841-1515
E-mail: susan.mancia@karlstorz.com

Social Media Profiles
More News From KARL STORZ

KARL STORZ Expands Its Robotics Ecosystem Through Strategic Partnerships in the US

TUTTLINGEN, Germany--(BUSINESS WIRE)--Through new strategic partnerships across the robotics ecosystem in the United States, the family-owned MedTech company KARL STORZ is bringing together advanced 3D visualization, robotic technologies, digital capabilities, and operating room integration. The collaborations with Moon Surgical and Sovato support a more open and connected approach to surgical innovation, designed to expand access, improve workflow efficiency, and enable future models of surgic...

KARL STORZ Announces FDA Clearance for Rubina Lens for Open Surgery

EL SEGUNDO, Calif.--(BUSINESS WIRE)--KARL STORZ, a global leader in endoscopic and minimally invasive surgical technology, has received FDA clearance for the Rubina™ Lens exoscope for open surgery, broadening the company’s near-infrared (NIR) imaging ecosystem across open and minimally invasive procedures in the United States. The digital, camera‑based Rubina™ Lens exoscope displays a real‑time, magnified 4K image of the surgical field on a monitor. With the ability to switch into NIR imaging u...

KARL STORZ Receives FDA Clearance for FIVE S 6.5 Bronchoscope

EL SEGUNDO, Calif.--(BUSINESS WIRE)--KARL STORZ, a global leader in endoscopic and minimally invasive surgical technology, has received FDA clearance for the FIVE S 6.5 sterile single-use bronchoscope. The device offers a valuable new option for critical care physicians, intensivists, RTs, and ICU-based proceduralists seeking airway control solutions for high-risk patients—especially those managing heavy secretions or in urgent situations requiring fast airway clearance. “The FIVE S 6.5 single-...
Back to Newsroom